Bereavement During a Course of TMS for MDD: A Case Report.

Psychopharmacology bulletin Pub Date : 2025-02-03

Gregory M Peterson, Karen Byrne, Tae Dillon, Ahmed Naguy, Yvonne Turnier-Shea, Marzena Rybak, Saxby Pridmore

{"title":"Bereavement During a Course of TMS for MDD: A Case Report.","authors":"Gregory M Peterson, Karen Byrne, Tae Dillon, Ahmed Naguy, Yvonne Turnier-Shea, Marzena Rybak, Saxby Pridmore","doi":"","DOIUrl":null,"url":null,"abstract":"Objective: A patient with major depressive disorder (MDD) was receiving transcranial magnetic stimulation (TMS). A little over halfway through the course the patient was bereaved and experienced normal sadness. Our objective is to describe the tracking and outcome of this common emotionally distressing event.Method: Routine assessments conducted at the centre include the six-item Hamiton depression rating (HAMD6) scale, the Clinical Global Impression-Severity (CGI-S) scale, and the Subjective Depression Scale (SDS6). In addition, the Daily Sadness Scale (DSS) is applied at each treatment day; this is a single question asking how much sadness/depression is being experienced.Results: On the 19th treatment day, the patient was bereaved and experienced appropriate sadness. The pathological state (MDD) resolved, as reflected by changes in the psychometric tools. Following the death, normal sadness emerged and lessened over a few weeks.Conclusion: This case illustrates that while TMS can effectively treat MDD, it does not prevent the emergence of sadness in uncomplicated bereavement.","PeriodicalId":94351,"journal":{"name":"Psychopharmacology bulletin","volume":"55 2","pages":"100-103"},"PeriodicalIF":0.0000,"publicationDate":"2025-02-03","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11809499/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Psychopharmacology bulletin","FirstCategoryId":"1085","ListUrlMain":"","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}

引用次数: 0

Abstract

Objective: A patient with major depressive disorder (MDD) was receiving transcranial magnetic stimulation (TMS). A little over halfway through the course the patient was bereaved and experienced normal sadness. Our objective is to describe the tracking and outcome of this common emotionally distressing event.

Method: Routine assessments conducted at the centre include the six-item Hamiton depression rating (HAMD6) scale, the Clinical Global Impression-Severity (CGI-S) scale, and the Subjective Depression Scale (SDS6). In addition, the Daily Sadness Scale (DSS) is applied at each treatment day; this is a single question asking how much sadness/depression is being experienced.

Results: On the 19th treatment day, the patient was bereaved and experienced appropriate sadness. The pathological state (MDD) resolved, as reflected by changes in the psychometric tools. Following the death, normal sadness emerged and lessened over a few weeks.

Conclusion: This case illustrates that while TMS can effectively treat MDD, it does not prevent the emergence of sadness in uncomplicated bereavement.

本刊更多论文

经颅磁刺激治疗重度抑郁症过程中的丧亲：一例报告。

目的：对重度抑郁症（MDD）患者进行经颅磁刺激治疗。在疗程过半的时候，病人失去亲人，经历了正常的悲伤。我们的目标是描述这种常见的情绪困扰事件的追踪和结果。方法：在中心进行常规评估，包括六项汉密尔顿抑郁评定量表（HAMD6）、临床总体印象严重程度量表（CGI-S）和主观抑郁量表（SDS6）。此外，在每个治疗日应用每日悲伤量表（DSS）；这是一个简单的问题，询问你经历了多少悲伤/抑郁。结果：在治疗第19天，患者丧失了亲人，并经历了适当的悲伤。病理状态（MDD）得到缓解，这反映在心理测量工具的变化上。在他死后，正常的悲伤会出现，并在几周内减轻。结论：本病例表明，虽然经颅磁刺激可以有效治疗重度抑郁症，但它并不能阻止单纯丧亲的悲伤情绪的出现。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

求助全文

约1分钟内获得全文求助全文

来源期刊

Psychopharmacology bulletin

自引率

0.00%

发文量